Concord Biotech Limited (NSE: CONCORDBIO)
India
· Delayed Price · Currency is INR 1,835.90
-17.80 (-0.96%)
Sep 6, 2024, 3:30 PM IST
Concord Biotech Revenue
Concord Biotech had revenue of 2.16B INR in the quarter ending June 30, 2024, with 10.77% growth. This brings the company's revenue in the last twelve months to 10.38B, up 19.71% year-over-year. In the fiscal year ending March 31, 2024, Concord Biotech had annual revenue of 10.17B with 19.20% growth.
Revenue (ttm)
10.38B
Revenue Growth
+19.71%
P/S Ratio
18.50
Revenue / Employee
7.54M
Employees
1,377
Market Cap
192.06B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 10.17B | 1.64B | 19.20% |
| Mar 31, 2023 | 8.53B | 1.40B | 19.67% |
| Mar 31, 2022 | 7.13B | 959.91M | 15.56% |
| Mar 31, 2021 | 6.17B | 1.05B | 20.42% |
| Mar 31, 2020 | 5.12B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries Limited | 9,252.89B |
| Tata Consultancy Services Limited | 2,441.25B |
| HDFC Bank Limited | 2,663.37B |
| Bharti Airtel Limited | 1,510.49B |
| ICICI Bank Limited | 1,686.78B |
| Infosys Limited | 1,555.41B |
| State Bank of India | 3,319.63B |
| Hindustan Unilever Limited | 621.07B |